A

Auven Therapeutics

9 employees

Auven Therapeutics is a private equity company focused on the healthcare industry.

Investor insights

Sectors invested in

Medical9
Biotechnology9
Biopharma6
Therapeutics6
Pharmaceutical3

Funding rounds participated in

$45M sweet spot round size

Most of their 10 investments are in rounds between $15M and $80M

Basic info

Industry

biotechnology research

Sectors

Health Care
Therapeutics
Advice

Date founded

2005

Investments made

A

ADC Therapeutics raised $76M on June 12, 2019

Investors: Redmile Group and Auven Therapeutics

A

ADC Therapeutics raised $200M on October 23, 2017

Investors: Redmile Group and Auven Therapeutics

A

ADC Therapeutics raised $105M on October 27, 2016

Investors: Auven Therapeutics

A

ADC Therapeutics raised $80M on September 2, 2015

Investors: EG Capital Advisors and Auven Therapeutics

A

ADC Therapeutics raised $40M on October 16, 2013

Investors: Auven Therapeutics

A

ADC Therapeutics raised $50M on March 26, 2012

Investors: Auven Therapeutics

K

Kolltan Pharmaceuticals, Inc raised $10M on January 20, 2010

Investors: Auven Therapeutics

U

Undisclosed raised $15M on October 22, 2009

Investors: Auven Therapeutics

K

Kolltan Pharmaceuticals, Inc raised $5M on October 12, 2009

Investors: Elm Street Ventures, Purdue Pharma L.P., Osage University Partners (OUP) and Auven Therapeutics

K

Kolltan Pharmaceuticals, Inc raised $40M on July 31, 2008

Investors: Purdue Pharma L.P., Osage University Partners (OUP) and Auven Therapeutics

FAQ